The post Alanis Morissette Charts A Career-First Top 10 Single appeared on BitcoinEthereumNews.com. Alanis Morissette’s “Coming Around Again,” featuring Carly Simon, debuts at No. 6 on Billboard’s Digital Song Sales chart, giving the “Ironic” singer a debut top 10. HAMILTON, ON – MARCH 15: Alanis Morissette is presented an award at the 2015 JUNO Awards at FirstOntario Centre on March 15, 2015 in Hamilton, Canada. (Photo by Sonia Recchia/Getty Images) Getty Images Decades into her career and years after first appearing on Billboard’s Digital Song Sales chart, Alanis Morissette scores a new hit this week. The Canadian singer-songwriter reaches the tally, which ranks the bestselling tunes throughout America, with a cover — and the original artist appears alongside the Grammy winner, as the two women score a career-best showing. “Coming Around Again” Opens Inside the Top 10 Morissette recently released her version of “Coming Around Again,” one of Carly Simon’s most famous singles. Both women are credited on the tune, which instantly becomes a strong seller in the United States. “Coming Around Again” launches at No. 6 on the Digital Song Sales chart with 2,700 pure purchases, according to Luminate. Alanis Morissette Scores Her First Top 10 Bestseller Morissette appears on the Digital Song Sales chart for the fourth time in her career, and “Coming Around Again” brings her to a never-before-seen high point. The collaboration marks her first trip to the top 10 and easily outpaces the No. 24 high point enjoyed by “Ablaze,” which she reached in 2020. “Ironic” and “You Oughta Know” Debuted Together In 2023, two of Morissette’s most famous cuts, “Ironic” and “You Oughta Know,” debuted on the Digital Song Sales ranking at the same time. In February, “Ironic” reached No. 32 as it arrived at its all-time high point. “You Oughta Know” lifted to No. 34 months after originally landing on the list. Alanis Morissette and Carly… The post Alanis Morissette Charts A Career-First Top 10 Single appeared on BitcoinEthereumNews.com. Alanis Morissette’s “Coming Around Again,” featuring Carly Simon, debuts at No. 6 on Billboard’s Digital Song Sales chart, giving the “Ironic” singer a debut top 10. HAMILTON, ON – MARCH 15: Alanis Morissette is presented an award at the 2015 JUNO Awards at FirstOntario Centre on March 15, 2015 in Hamilton, Canada. (Photo by Sonia Recchia/Getty Images) Getty Images Decades into her career and years after first appearing on Billboard’s Digital Song Sales chart, Alanis Morissette scores a new hit this week. The Canadian singer-songwriter reaches the tally, which ranks the bestselling tunes throughout America, with a cover — and the original artist appears alongside the Grammy winner, as the two women score a career-best showing. “Coming Around Again” Opens Inside the Top 10 Morissette recently released her version of “Coming Around Again,” one of Carly Simon’s most famous singles. Both women are credited on the tune, which instantly becomes a strong seller in the United States. “Coming Around Again” launches at No. 6 on the Digital Song Sales chart with 2,700 pure purchases, according to Luminate. Alanis Morissette Scores Her First Top 10 Bestseller Morissette appears on the Digital Song Sales chart for the fourth time in her career, and “Coming Around Again” brings her to a never-before-seen high point. The collaboration marks her first trip to the top 10 and easily outpaces the No. 24 high point enjoyed by “Ablaze,” which she reached in 2020. “Ironic” and “You Oughta Know” Debuted Together In 2023, two of Morissette’s most famous cuts, “Ironic” and “You Oughta Know,” debuted on the Digital Song Sales ranking at the same time. In February, “Ironic” reached No. 32 as it arrived at its all-time high point. “You Oughta Know” lifted to No. 34 months after originally landing on the list. Alanis Morissette and Carly…

Alanis Morissette Charts A Career-First Top 10 Single

2015 JUNO Awards - Show

Alanis Morissette’s “Coming Around Again,” featuring Carly Simon, debuts at No. 6 on Billboard’s Digital Song Sales chart, giving the “Ironic” singer a debut top 10. HAMILTON, ON – MARCH 15: Alanis Morissette is presented an award at the 2015 JUNO Awards at FirstOntario Centre on March 15, 2015 in Hamilton, Canada. (Photo by Sonia Recchia/Getty Images)

Getty Images

Decades into her career and years after first appearing on Billboard’s Digital Song Sales chart, Alanis Morissette scores a new hit this week. The Canadian singer-songwriter reaches the tally, which ranks the bestselling tunes throughout America, with a cover — and the original artist appears alongside the Grammy winner, as the two women score a career-best showing.

“Coming Around Again” Opens Inside the Top 10

Morissette recently released her version of “Coming Around Again,” one of Carly Simon’s most famous singles. Both women are credited on the tune, which instantly becomes a strong seller in the United States. “Coming Around Again” launches at No. 6 on the Digital Song Sales chart with 2,700 pure purchases, according to Luminate.

Alanis Morissette Scores Her First Top 10 Bestseller

Morissette appears on the Digital Song Sales chart for the fourth time in her career, and “Coming Around Again” brings her to a never-before-seen high point. The collaboration marks her first trip to the top 10 and easily outpaces the No. 24 high point enjoyed by “Ablaze,” which she reached in 2020.

“Ironic” and “You Oughta Know” Debuted Together

In 2023, two of Morissette’s most famous cuts, “Ironic” and “You Oughta Know,” debuted on the Digital Song Sales ranking at the same time. In February, “Ironic” reached No. 32 as it arrived at its all-time high point. “You Oughta Know” lifted to No. 34 months after originally landing on the list.

Alanis Morissette and Carly Simon, Together

Morissette re-recorded “Coming Around Again” to be featured in the film My Mother’s Wedding, which stars Scarlett Johansson, Sienna Miller, and Freida Pinto. The original version of “Coming Around Again” was released by Simon in 1986, and it was also included on the soundtrack for the film Heartburn. After it became a worldwide hit, Simon placed it on an album of the same name, which followed and benefited from the immense popularity of the track.

Source: https://www.forbes.com/sites/hughmcintyre/2025/08/21/alanis-morissette-charts-a-career-first-top-10-single/

Market Opportunity
Seed.Photo Logo
Seed.Photo Price(PHOTO)
$0.194
$0.194$0.194
0.00%
USD
Seed.Photo (PHOTO) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow

The first-ever ETFs for XRP and Dogecoin are expected to launch in the US tomorrow. Here's what you need to know. Continue Reading: And the Big Day Has Arrived: The Anticipated News for XRP and Dogecoin Tomorrow
Share
Coinstats2025/09/18 04:33
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution

The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26
Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

Rising Altcoin Inflows Signal Potential Market Sell-Off: CryptoQuant

        Highlights:  Inflows of altcoins in exchanges have surged by 22% in early 2026. An increase in deposits indicates a growing sell-side pressure. The 
Share
Coinstats2026/02/22 02:03